How do you pay?

How to pay the least

Ask for the cash price

Leukine

Leukine is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Leukine’s cash price, and one or two other pharmacies too.

Compare every option

Question
Brand nameLeukine
Authorized genericsargramostim
Regular genericsargramostim
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Leukine?
The original
–
–

Brand nameThe maker’s card

LeukineDirect / PTx Assist Copay Program

Savings card from Partner Therapeutics

Leukine’s maker has a savings program. Its page doesn’t list a dollar amount.

Sign up on ptxassist.com 

Or call 1-877-353-8546.

From the maker’s site, checked November 2, 2026. Check the maker’s page for who can use it.

Authorized genericNot sold

There isn’t one. An authorized generic is Leukine itself, from the same company, sold without the brand name, and usually for less. For now Leukine is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Leukine is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

LEUKINE is a leukocyte growth factor indicated:

  • To shorten time to neutrophil recovery and to reduce the incidence of severe and life-threatening infections and infections resulting in death following induction chemotherapy in adult patients 55 years and older with acute myeloid leukemia (AML).
  • For the mobilization of hematopoietic progenitor cells into peripheral blood for collection by leukapheresis and autologous transplantation in adult patients.
  • For the acceleration of myeloid reconstitution following autologous bone marrow or peripheral blood progenitor cell transplantation in adult and pediatric patients 2 years of age and older.
  • For the acceleration of myeloid reconstitution following allogeneic bone marrow transplantation in adult and pediatric patients 2 years of age and older.
  • For treatment of delayed neutrophil recovery or graft failure after autologous or allogeneic bone marrow transplantation in adult and pediatric patients 2 years of age and older.
  • To increase survival in adult and pediatric patients from birth to 17 years of age acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome [H-ARS]).

Source: the FDA label for Leukine (Partner Therapeutics, Inc.), December 6, 2024. Full label on DailyMed 

Good to know